Columbia Sportswear Co (COLM) · Oct 29, 2026 · Earnings
Beat — Diluted EPS $1.66 vs ~$1.28 consensus; revenue $962.6M vs ~$944.9M
Columbia Sportswear earnings beat Q3 expectations and lifted the low end of full-year guidance, though inventory and cash-flow pressures remain.
Columbia Sportswear is midway through a multi-year ACCELERATE repositioning aimed at making its core Columbia brand more relevant to younger, more active consumers, while trying to repair weak U.S. demand through direct-to-consumer growth. That backdrop remains mixed: the strategy is showing traction in digital DTC and international markets, but the U.S. wholesale business is still being affected by order-timing shifts.
The quarter beat a relatively low bar by a wide margin. Q3 revenue was $962.6 million versus roughly $944.9 million expected, while diluted EPS was $1.66 versus approximately $1.28 consensus. Revenue grew 2% year over year, but the quality of the beat matters: DTC rose 5% and rose 9%, while wholesale was flat, with delayed Fall ’26 orders shifting between quarters. The filing states, “Net sales increased 2 percent (2 percent constant-currency) to $962.6million from $943.4million for the comparable period in 2025.”
| Metric | Q3 2026 | Q3 2025 | Consensus / prior guidance |
|---|---|---|---|
| Revenue (Financial Results) | $962.6M | $943.4M | ~$944.9M |
| Diluted EPS (Financial Results) | $1.66 | $0.95 | ~$1.28 |
| Gross margin (Financial Results) | 49.8% | 50.0% | |
| Inventory (Balance Sheet) | $889.2M | $800.4M | |
| FY revenue outlook (Financial Outlook) | $3.46B–$3.50B | $3.40B actual | Prior $3.43B–$3.50B |
| FY diluted EPS outlook (Financial Outlook) | $4.65–$4.90 | Prior $4.45–$4.90 | |
| FY operating cash flow outlook (Financial Outlook) | $230M–$250M | Prior $290M–$310M |
The earnings beat is better than the headline EPS growth suggests, but not entirely organic. EPS benefited from the absence of last year’s $29 million impairment charge and from tariff refunds; management says those refunds increased nine-month reported EPS by $0.85 and are expected to add roughly $0.97 to full-year reported EPS. The filing states, “Net income of $84.7million, or $1.66per diluted share, compared to net income of $52.0million, or $0.95per diluted share, for the comparable period in 2025.”
The operating story improved, but the U.S. turnaround is not complete. International sales were the main growth engine, led by Latin America and Asia Pacific and EMEA, while U.S. sales fell 1%. The more encouraging signal is that U.S. DTC grew, especially e-commerce, supporting the ACCELERATE thesis; the less encouraging signal is that wholesale remained flat and Mountain Hardwear declined 17% in the quarter. Gross margin also contracted 20 basis points to 49.8%, partly because Columbia accommodated factory partners, meaning the revenue beat did not translate into underlying margin expansion.
The main offset is working-capital intensity. Inventory rose 11% to $889.2 million as delayed Fall receipts and earlier Spring 2027 production pulled cash forward. The filing states, “Inventories increased 11 percent to $889.2million, compared to $800.4million as of September 30, 2025.” Management still calls the mix healthy, but the consequence is meaningful: full-year operating-cash-flow guidance was cut to $230–$250 million from $290–$310 million. That makes the quarter’s earnings beat less clean than the headline numbers imply.
Guidance was raised, but only at the low end. The full-year revenue range moved from $3.43–$3.50 billion to $3.46–$3.50 billion, and the EPS floor rose from $4.45 to $4.65; gross-margin guidance was unchanged. The filing states, “Net sales are expected to increase 2.0 to 3.0 percent (prior 1.0 to 3.0 percent), resulting in net sales of $3.46to $3.50billion (prior $3.43to $3.50billion), compared to $3.40billion in 2025.” The raise reflects delayed wholesale orders moving into Q4 and better U.S. DTC trends, so it advances the story, but does not yet prove a durable U.S. wholesale recovery.
Bottom line: Columbia delivered a clear Q3 earnings beat and modestly improved its full-year outlook, with DTC and international demand validating parts of the turnaround. The read is positive, but the benefit is tempered by tariff-driven earnings support, elevated inventory, and a sizable cash-flow downgrade.
Q4 2026 report and remaining Fall ’26 wholesale shipments
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!